News Sentiment

MAAT sentiment intelligence

MaaT Pharma SA news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 48 Balanced news tone 7 relevant articles
Exchange PAR France
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.86 Week of 19 Jun 2026
Weighted tone 48/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 7

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-2.9% over one week, -12.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): Under review

Market Reaction

Balanced read

60/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction -2.9% Price reacting lower
Trend fit Trend inactive -12.3% over four weeks
Fair value -55.7% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 6
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 7
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Idéal Investisseur 2
TradingView 1
Investing.com 1
simplywall.st 1
Clinical Trials Arena 1
marketscreener.com 1

Event Lens

What the news is about

Classified themes
Market update 5
Earnings 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-7 of 7